Related Experiment Video
Updated: Jul 19, 2026
08:50
5/6th Nephrectomy in Combination with High Salt Diet and Nitric Oxide Synthase Inhibition to Induce Chronic Kidney Disease in the Lewis Rat
Published on: July 3, 2013
Parathyroidectomy in chronic renal failure: a nine-year follow-up study
The Quarterly Journal of Medicine
|November 1, 1990
Summary
Parathyroidectomy significantly improved hyperparathyroidism markers in chronic renal failure patients. Controlling serum phosphate and calcium x phosphate product is crucial for preventing vascular calcification.
Area of Science:
- Nephrology
- Endocrinology
- Surgical Pathology
Background:
- Secondary hyperparathyroidism is a common complication in patients with chronic renal failure.
- Parathyroidectomy is a surgical option for managing severe secondary hyperparathyroidism.
- Long-term outcomes and recurrence rates of different parathyroidectomy techniques require further investigation.
Purpose of the Study:
- To evaluate the long-term efficacy of sub-total parathyroidectomy versus total parathyroidectomy with autograft in patients with chronic renal failure.
- To assess the impact of parathyroidectomy on biochemical markers and bone histology.
- To determine the relationship between calcium x phosphate product and vascular calcification.
Main Methods:
- Retrospective review of 73 patients with chronic renal failure who underwent parathyroidectomy between 1978 and 1987.
- Comparison of sub-total parathyroidectomy (34 patients) and total parathyroidectomy with autograft (39 patients).
- Analysis of pre- and post-operative parathyroid hormone, calcium, alkaline phosphatase, and calcium x phosphate product levels, along with bone histology and vascular calcification assessment.
Main Results:
- Both surgical techniques led to significant improvements in parathyroid hormone, calcium, and alkaline phosphatase levels, and reduced calcium x phosphate product.
- Recurrence of hyperparathyroidism was low for both methods (2/34 for sub-total, 4/39 for total with autograft).
- Higher calcium x phosphate product was associated with increased vascular calcification, suggesting a target product of <4.2 and serum phosphate of ≤1.8 mmol/L.
Conclusions:
- Both sub-total parathyroidectomy and total parathyroidectomy with autograft are effective in managing secondary hyperparathyroidism in chronic renal failure patients.
- Maintaining a low calcium x phosphate product is critical for preventing or reducing vascular calcification in end-stage renal disease patients.
- Close monitoring of serum phosphate and calcium x phosphate product is essential for long-term patient outcomes.
Related Concept Videos
01:26Kidney Transplant II: Surgical Procedure
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living donor...
01:16Kidney Transplant III: Nursing Management
Postoperative Nursing Management for Kidney Transplant PatientsPostoperative nursing management care includes monitoring the surgical site, encouraging early movement, and promoting lung health through breathing exercises. Nurses also administer prescribed medications like H2-blockers, such as famotidine, or proton pump inhibitors, like omeprazole, to help prevent gastrointestinal ulcers and bleeding. Fungal infections in the mouth and bladder can result from immunosuppressive and antibiotic...
01:29Acute Kidney Injury III: Clinical Manifestations
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
01:25Chronic Kidney Disease I: Introduction
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
01:24Chronic Kidney Disease II: Clinical Manifestations
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
01:28Chronic Kidney Disease III: Interprofessional Care
Chronic kidney disease (CKD) requires collaborative and comprehensive management. CKD progresses through stages and can lead to end-stage kidney disease (ESKD) if untreated. Interprofessional collaboration and patient education are crucial, enabling patients to manage their health and improve their quality of life.Diagnostic approach for chronic kidney diseaseThe diagnosis of CKD primarily focuses on the glomerular filtration rate (GFR), which assesses kidney function by measuring how well...